Skip to search boxSkip to navigationSkip to main content

Functional consequences of repeated organophosphate exposure: Potential non-cholinergic mechanisms

*Corresponding author for this work
  • Medical College of Georgia
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

The class of chemicals known as the "organophosphates" (OPs) comprises many of the most common agricultural and commercial pesticides that are used worldwide as well as the highly toxic chemical warfare agents. The mechanism of the acute toxicity of OPs in both target and non-target organisms is primarily attributed to inhibitory actions on various forms of cholinesterase leading to excessive peripheral and central cholinergic activity. However, there is now substantial evidence that this canonical (cholinesterase-based) mechanism cannot alone account for the wide-variety of adverse consequences of OP exposure that have been described, especially those associated with repeated exposures to levels that produce no overt signs of acute toxicity. This type of exposure has been associated with prolonged impairments in attention, memory, and other domains of cognition, as well as chronic illnesses where these symptoms are manifested (e.g., Gulf War Illness, Alzheimer's disease). Due to their highly reactive nature, it is not surprising that OPs might alter the function of a number of enzymes and proteins (in addition to cholinesterase). However, the wide variety of long-term neuropsychiatric symptoms that have been associated with OPs suggests that some basic or fundamental neuronal process was adversely affected during the exposure period. The purpose of this review is to discuss several non-cholinesterase targets of OPs that might affect such fundamental processes and includes cytoskeletal and motor proteins involved in axonal transport, neurotrophins and their receptors, and mitochondria (especially their morphology and movement in axons). Potential therapeutic implications of these OP interactions are also discussed.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 355-365 (11 pages)

Journal (Volume, Issue Number)

Pharmacology and Therapeutics (Volume 134, Issue 3)

Publication milestones

  • Published - 06/2012

Publication status

Published - 06/2012

ISSN

0163-7258

Publication IDs

  • Scopus: 84859788265
  • PubMed: 22465060

Publication metrics

Metrics

SciVal
FWCI
2.06
SciVal
Author count
1
SciVal
citations
141
SciVal
Paper percentile
98
SciVal
Top percentile
5
Scopus
citations
Fractional count
1
Fractional count
1
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Mentions
3
Captures
294
Social media
100
Citation count
233

Funding Details

The authors would like to thank Ms. Ashley Davis for her administrative assistance in preparing this article. This author's laboratory is currently supported by the National Institute of Environmental Health Sciences ( ES012241 ), the National Institute on Aging ( AG029617 ), and the National Institute on Drug Abuse ( DA029127 ).